SEC Form 4 · accession 0001657070-18-000017
KEWAUNEE SCIENTIFIC CORP /DE/ · KEQU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M. Rausch
Officer — President, CEO · Director
Period of report
Jul 10, 2018
Accepted (ET)
Jul 11, 2018 · 9:58 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000055529
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 10, 2018 | M | 4,000 | $11.78 | A | 16,541 | D | |
| Common Stock | Jul 10, 2018 | F | 1,415 | $33.30 | D | 15,126 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to BuyF2 | $11.78 | Jul 10, 2018 | M | 4,000 | D | Aug 22, 2015 | Aug 22, 2022 | Common Stock | 4,000 | 4,000 | D |
Explanation of responses
- F1Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon this exercise as reported below on this Form 4 report.
- F2Employee stock option granted under Employee Stock Option Plan under Rule 16b-3.